Nurix Therapeutics, Inc
- Biotech or pharma, therapeutic R&D
Nurix is a leader in the emerging field of targeted protein degradation (TPD) with a clinical pipeline of three wholly owned assets, multiple partnerships with Gilead, Sanofi, and Pfizer, a deep pipeline and expertise across the both small molecule degraders and degrader antibody conjugates.
Address
San FranciscoCalifornia
United States
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}